Clinical Trial Update: A Phase II Clinical Study on the Efficacy and Safety of HRS-1780 in Participants With Primary Aldosteronism [Phase 2]

View source ↗

Summary

A Phase II clinical trial evaluating the efficacy and safety of HRS-1780 in patients with primary aldosteronism has been announced, with recruitment not yet sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aldosteronism

Drugs mentioned

• HRS-1780

Snippet

Sponsor: Shandong Suncadia Medicine Co., Ltd. | Conditions: Primary Aldosteronism | Phase 2 | Status: NOT_YET_RECRUITING